RecruitingNot Applicable

The Role of Ceus in the Characterization of Focal Liver Lesions Indeterminate to Second-level Methods

Italy100 participantsStarted 2024-08-01

Plain-language summary

The primary objective of the study is to determine the accuracy of CEUS in characterizing (as benign or malignant) focal liver lesions for which CT, MRI and/or PET have not been conclusive.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥18 years. * CEUS performed performed in the last 6 months a CT, MRI and/or PET not decisive in characterizing a liver lesion. * Obtaining informed consent. Exclusion Criteria: * Technical impossibility to perform the ultrasound evaluation. * Documented allergy to the ultrasound contrast medium.

What they're measuring

CEUS diagnostic accuracy

Timeframe: 2 years

Trial details

NCT IDNCT06876805

SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-08-01

Contact for this trial

Carla Serra, PhD

+390512143270 carla.serra@aosp.bo.it

View on ClinicalTrials.gov More Focal Liver Lesion trials